| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 877* | 2021 |
| Therapeutic anticoagulation with heparin in critically ill patients with Covid-19 EC Goligher, CA Bradbury, BJ McVerry, PR Lawler, JS Berger, MN Gong, ... New England Journal of Medicine 385 (9), 777-789, 2021 | 562 | 2021 |
| Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19 JS Berger, D Kunichoff, S Adhikari, T Ahuja, N Amoroso, ... Arteriosclerosis, thrombosis, and vascular biology 40 (10), 2539-2547, 2020 | 236 | 2020 |
| Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients PM Carlucci, T Ahuja, C Petrilli, H Rajagopalan, S Jones, J Rahimian Journal of medical microbiology 69 (10), 1228-1234, 2020 | 173 | 2020 |
| Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients PM Carlucci, T Ahuja, C Petrilli, H Rajagopalan, S Jones, J Rahimian MedRxiv, 2020 | 98 | 2020 |
| Thromboelastography profiles of critically ill patients with coronavirus disease 2019 E Yuriditsky, JM Horowitz, C Merchan, T Ahuja, SB Brosnahan, L McVoy, ... Critical care medicine 48 (9), 1319-1326, 2020 | 92 | 2020 |
| Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage JA Frontera, P Bhatt, R Lalchan, S Yaghi, T Ahuja, J Papadopoulos, ... Journal of thrombosis and thrombolysis, 1-11, 2020 | 81 | 2020 |
| Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... Jama 329 (13), 1066-1077, 2023 | 68 | 2023 |
| Phenibut (β‐Phenyl‐γ‐aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse T Ahuja, O Mgbako, C Katzman, A Grossman Case reports in psychiatry 2018 (1), 9864285, 2018 | 38 | 2018 |
| Anticoagulation prescribing patterns in patients with cancer E Xiang, T Ahuja, V Raco, F Cirrone, D Green, J Papadopoulos Journal of Thrombosis and Thrombolysis 45, 89-98, 2018 | 33 | 2018 |
| Extended-infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center SR Cutro, R Holzman, Y Dubrovskaya, XJC Chen, T Ahuja, MR Scipione, ... Antimicrobial agents and chemotherapy 58 (8), 4470-4475, 2014 | 33 | 2014 |
| Combination antifungal therapy for treatment of Candida parapsilosis prosthetic valve endocarditis and utility of T2Candida Panel®: A case series T Ahuja, K Fong, E Louie IDCases 15, e00525, 2019 | 20 | 2019 |
| Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome K Phillips, F Cirrone, T Ahuja, J Siegfried, J Papadopoulos Journal of Oncology Pharmacy Practice 25 (2), 398-403, 2019 | 17 | 2019 |
| Antithrombotic stewardship: assessing use of computerized clinical decision support tools to enhance safe prescribing of direct oral anticoagulants in hospitalized patients T Ahuja, V Raco, J Papadopoulos, D Green Journal of patient safety 17 (8), e1057-e1061, 2021 | 16 | 2021 |
| A comparison of prothrombin complex concentrate and recombinant activated factor VII for the management of bleeding with cardiac surgery A Katz, T Ahuja, S Arnouk, TC Lewis, K Marsh, J Papadopoulos, ... Journal of intensive care medicine 37 (2), 231-239, 2022 | 15 | 2022 |
| Evaluation of direct oral anticoagulants versus warfarin for intracardiac thromboses O Iskaros, K Marsh, J Papadopoulos, A Manmadhan, T Ahuja Journal of Cardiovascular Pharmacology 77 (5), 621-631, 2021 | 14 | 2021 |
| COVID-19 pandemic preparedness: A practical guide from an operational pharmacy perspective C Merchan, J Soliman, T Ahuja, S Arnouk, K Keeley, J Tracy, G Guerra, ... American Journal of Health-System Pharmacy 77 (19), 1598-1605, 2020 | 14 | 2020 |
| Enoxaparin dosing and antiXa monitoring in specialty populations: a case series of renal-impaired, extremes of body weight, pregnant, and pediatric patients T Ahuja, KM Mousavi, L Klejmont, S Desai Pharmacy and Therapeutics 43 (10), 609, 2018 | 13 | 2018 |
| Assessment of patients post reversal with idarucizumab V Raco, T Ahuja, D Green Journal of Thrombosis and Thrombolysis 46 (4), 466-472, 2018 | 12 | 2018 |
| Renal and cardiac implications of sodium glucose cotransporter 2 (SGLT2) inhibitors: the state of the science JE Cruz, T Ahuja, MB Bridgeman Annals of Pharmacotherapy 52 (12), 1238-1249, 2018 | 9 | 2018 |
